Detalhe da pesquisa
1.
Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA.
Brief Bioinform
; 24(1)2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611239
2.
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
Int J Mol Sci
; 22(18)2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34575974
3.
Metabolomic profiling in neuroblastoma.
Pediatr Blood Cancer
; 67(3): e28113, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31802629
4.
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.
Int J Mol Sci
; 21(8)2020 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32295184
5.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1617-1629, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442501
6.
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.
Br J Cancer
; 118(11): 1502-1512, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755120
7.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Lancet Oncol
; 18(4): 500-514, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28259608
8.
Advances in emerging drugs for the treatment of neuroblastoma.
Expert Opin Emerg Drugs
; 22(1): 63-75, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28253830
9.
A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors.
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28121069
10.
Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440012
11.
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort.
Br J Cancer
; 115(4): 480-9, 2016 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27415013
12.
Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
J Pediatr Hematol Oncol
; 38(3): 176-81, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26925713
13.
Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
J Pediatr Hematol Oncol
; 37(5): e272-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25374283
14.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
J Clin Oncol
; 42(10): 1135-1145, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190578
15.
Emerging drugs for neuroblastoma.
Expert Opin Emerg Drugs
; 18(2): 155-71, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692586
16.
Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas.
Front Oncol
; 13: 1037342, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251933
17.
Alternative lengthening of telomeres--an enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas.
Genes Chromosomes Cancer
; 50(4): 250-62, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21319260
18.
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition.
Eur J Hum Genet
; 30(11): 1288-1291, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459888
19.
Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.
Mol Carcinog
; 50(3): 153-62, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21104989
20.
Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content.
Histopathology
; 59(1): 22-30, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21668478